What is the prevalence of Devic Syndrome / NMO?
How many people does Devic Syndrome / NMO affect? Does it have the same prevalence in men and women? And in the different countries?
Devic Syndrome, also known as Neuromyelitis Optica (NMO), is a rare autoimmune disorder affecting the central nervous system. It primarily targets the optic nerves and spinal cord, causing severe inflammation and damage. While considered rare, the prevalence of Devic Syndrome varies geographically. In some populations, it affects approximately 1-10 individuals per 100,000, with a higher incidence in certain ethnic groups. Early diagnosis and treatment are crucial to manage symptoms and prevent disability. Research and awareness efforts continue to shed light on this complex syndrome.
Devic Syndrome, also known as Neuromyelitis Optica (NMO), is a rare autoimmune disorder that primarily affects the optic nerves and spinal cord. It is characterized by recurrent episodes of optic neuritis, which causes inflammation and damage to the optic nerves, leading to vision loss. Additionally, it involves inflammation of the spinal cord, resulting in weakness or paralysis of the limbs, loss of sensation, and bladder and bowel dysfunction.
The prevalence of Devic Syndrome/NMO varies across different populations. It is estimated to affect approximately 1 to 10 individuals per 100,000 people worldwide. However, prevalence rates can be higher in certain ethnic groups, such as individuals of African or Asian descent. Women are also more commonly affected than men, with a female-to-male ratio of around 4:1.
While Devic Syndrome/NMO is considered a rare condition, it is important to note that prevalence rates may be underestimated due to misdiagnosis or underreporting. The disorder can have a significant impact on the quality of life of those affected, requiring ongoing medical management and support.
Posted Jul 6, 2018 by Ravi 1500
